1. Home
  2. CHRS vs CLAR Comparison

CHRS vs CLAR Comparison

Compare CHRS & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$1.62

Market Cap

186.0M

Sector

Health Care

ML Signal

N/A

Logo Clarus Corporation

CLAR

Clarus Corporation

N/A

Current Price

$3.66

Market Cap

129.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
CHRS
CLAR
Founded
2010
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
186.0M
129.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CHRS
CLAR
Price
$1.62
$3.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.02
$5.33
AVG Volume (30 Days)
1.2M
115.5K
Earning Date
03-09-2026
03-05-2026
Dividend Yield
N/A
2.84%
EPS Growth
N/A
N/A
EPS
1.34
N/A
Revenue
$277,728,000.00
$256,432,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$67.31
$3.85
P/E Ratio
$1.23
N/A
Revenue Growth
152.07
N/A
52 Week Low
$0.71
$3.02
52 Week High
$1.89
$5.08

Technical Indicators

Market Signals
Indicator
CHRS
CLAR
Relative Strength Index (RSI) 60.19 58.81
Support Level $1.51 $3.50
Resistance Level $1.72 $3.86
Average True Range (ATR) 0.13 0.13
MACD 0.01 0.02
Stochastic Oscillator 70.47 72.97

Price Performance

Historical Comparison
CHRS
CLAR

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: